NCT01007240Unknown1 期
Clinical Study of the Antibacterial Properties of the Nano Particles Which Incorporated With the Soft Liner Silicone - in Obturators
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 10
- 主要终点
- bacterial growth
研究概览
简要总结
The aim of this study is to evaluate the antibacterial activity of crosslinked quaternary ammonium polyethylenimine (PEI) nanoparticles incorporated at 1-2% w/w in a commercial soft liner material when compared to the commercial soft liner material.
The investigators' results in vitro showed a significant delay in bacterial growth.
Therefore, the investigators assume to have the same delay in vivo- on patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients post maxillectomy, who are using obturators
排除标准
- •patients who are not using obturators
结局指标
主要结局
bacterial growth
时间窗: a week
次要结局
未报告次要终点
研究者
相似试验
尚未招募
1 期
A study of antibacterial activities and mechanism of action of Ha-Rak against common pathogenic bacteria in Thailand.Antibiotic-resistant bacteria in Thailand.Acinetobacter baumannii,Pseudomonas aeruginosa,Enterococcus spp.,Escherichia coli,Staphylococcus aureus,Klebsiella pneumoniae,Ha-Rak,antimicrobial peptides,serum bactericidal activities,inflaTCTR20200731002Faculty of medicine siriraj hospital, Mahidol university30
已完成
不适用
Chlorhexidine coated and non-coated resorbable sutures with and without oral rinse in reducing bacterial contamination in periodontal flap surgeriesCTRI/2021/11/037931Radhika Kherdekar40
尚未招募
2 期
A clinical trial to study the effect of four intracanal medicaments in teeth with apical periodontitisCTRI/2021/05/033716Iffat Nasim
尚未招募
1 期
Antibacterial activity of Novel herbal intracanal medicaments against endodontic pathogens.CTRI/2021/12/038772DrSheetal Ghivari
已完成
2 期
A clinical trial to study the effects of Tulsi (Holy basil) on immune status of healthy human subjectsCTRI/2009/091/000350Immunomodulatory trial is sponsered by CCRAS60
